Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/31/2014 9:06:49 AM - Followers: 498 - Board type: Free - Posts Today: 62

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Securities Registration Statement (simplified Form) (s-3) 10/30/2014 04:31:15 PM
CTIX News: Current Report Filing (8-k) 10/24/2014 06:04:28 AM
CTIX News: ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK 10/14/2014 06:00:00 AM
CTIX News: Current Report Filing (8-k) 09/24/2014 03:48:22 PM
CTIX News: Annual Report (10-k) 09/15/2014 01:50:04 PM
News News Alert: Securities Registration Statement (simplified Form) (s-3) 10/30/2014 04:31:15 PM
PostSubject
#75955  Sticky Note NYSE listing requirements and Nasdaq listing requirements... BooDog 10/29/14 04:10:14 PM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#73082  Sticky Note Patrick Cox interviews Cellceutix Executives Dr. Menon & sox040713 10/09/14 04:20:59 PM
#69616  Sticky Note Based on the stock movement, I think that BioHedge 09/16/14 06:47:44 PM
#67831  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and KarinCA 09/03/14 06:13:02 PM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#76254   What I see — and what I think DaubersUP 10/31/14 09:06:49 AM
#76253   That would be true if Pfizer (or some frrol 10/31/14 09:05:20 AM
#76252   Spot on, D UP. eventhelosers 10/31/14 09:00:01 AM
#76251   I'm very surprised by their consideration of acquisitions, frrol 10/31/14 08:54:27 AM
#76250   I sincerely disagree. If I'm Pfizer and DaubersUP 10/31/14 08:50:01 AM
#76249   lol...and yes Go CTIX...everything is looking pretty damn Looping 10/31/14 08:49:24 AM
#76248   "don't poke the bear".... Go ctix Apparition 10/31/14 08:44:55 AM
#76247   Please don't get him started... Looping 10/31/14 08:38:44 AM
#76246   This was not an attempt to do anything frrol 10/31/14 08:38:06 AM
#76245   Nice PR today! I was a little nervous waikikian 10/31/14 08:33:48 AM
#76244   I keep hearing the word "acquisition" in their ShinSekai 10/31/14 08:32:17 AM
#76243   Pre-market says up, but it's only 2500 shares TheDane 10/31/14 08:31:58 AM
#76242   A little pre market action. carpetdude 10/31/14 08:31:14 AM
#76241   Thanks for the cheap shares Wednesday! I'm daydreaming2 10/31/14 08:27:26 AM
#76240   Love it! smitter 10/31/14 08:26:54 AM
#76239   George will be thrilled to read that part! cabel 10/31/14 08:26:25 AM
#76238   Please do stick around for a while. This Apparition 10/31/14 08:26:00 AM
#76237   Welcome back Wild...Miss your enthusiasm... scgmck1 10/31/14 08:25:38 AM
#76236   I really like the PR. Nice write up Apparition 10/31/14 08:23:33 AM
#76235   Many biotechs surge on an S3 given the alexwv 10/31/14 08:15:58 AM
#76234   B expedited path? From todays PR "We plan to leverage Amatuer17 10/31/14 08:15:36 AM
#76233   A Wild4 spotting!!!!! Go CTIX Matagordaville 10/31/14 08:12:18 AM
#76232   Cellceutix's New Chief Operating Officer Dr. James Alexander oldguy76 10/31/14 08:05:06 AM
#76231   GOING AHEAD WITH K FOR ONE AND MAYBE govorchin 10/31/14 08:04:25 AM
#76230   Bravo! jok 10/31/14 08:02:30 AM
#76229   COO is talking. It's all good! monkeyplay1 10/31/14 08:00:32 AM
#76228   This is good! 'We're under no pressure monkeyplay1 10/31/14 07:53:00 AM
#76227   Here we go again. Can't keep your business TheDane 10/31/14 07:52:01 AM
#76226   Very good letter of introduction by the COO. TheDane 10/31/14 07:48:52 AM
#76225   Metaphor of the day. If you have F1ash 10/31/14 07:44:58 AM
#76224   I for one am happy to know the noretreat 10/31/14 07:37:29 AM
#76223   I especially like the way K was brought Tails 10/31/14 07:37:05 AM
#76222   Good luck with that. noretreat 10/31/14 07:31:03 AM
#76221   Authorized Shares - Amatuer17 10/31/14 07:29:34 AM
#76220   BEAUTIFUL in EVERY WAY ! I love this wild4ctix 10/31/14 07:27:47 AM
#76219   I am afraid you will get burned. NanoEngineer 10/31/14 07:27:22 AM
#76218   There is dilution and there is value. If TheDane 10/31/14 07:24:43 AM
#76217   Nice music for the w-e rosalieone 10/31/14 07:21:50 AM
#76216   Ill be the first to admit I didn't Ultimate01 10/31/14 07:19:56 AM
#76215   Nevermind. .this is our COO., should have look Vlady 1 10/31/14 07:11:43 AM
#76214   to Jok & 1400 news too... I was BooDog 10/31/14 07:10:08 AM
#76213   Well now, PR..new board members, S-3..now I can Vlady 1 10/31/14 07:09:08 AM
#76212   NEW PR... JohnnySticks 10/31/14 07:06:39 AM
#76211   I just think when you raise money from 1400 10/31/14 06:58:35 AM
#76210   This shelf registration can't be acted upon for jok 10/31/14 06:55:17 AM
#76209   Let's say Leo wants to secure a facility BooDog 10/31/14 06:27:54 AM
#76208   Johnny, you are correct. Not enough coffee 58nout 10/31/14 06:19:15 AM
#76207   It's a shelf registration not to exceed $75M, BooDog 10/31/14 06:09:07 AM
#76206   CTIX MAY sell $75M in shares or other JohnnySticks 10/31/14 06:02:39 AM
#76205   I am not that familiar with the S-3 Vlady 1 10/31/14 05:56:10 AM
PostSubject